{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:56:33Z","timestamp":1791161793329,"version":"4.1.0"},"reference-count":60,"publisher":"American Diabetes Association","issue":"7","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:p>First-degree relatives of individuals with type 2 diabetes are at increased risk of developing hyperglycemia. To examine the prevalence and pathogenesis of abnormal glucose homeostasis in these subjects, 531 first-degree relatives with no known history of diabetes (aged 44.1 \u00b1 0.7 years; BMI 29.0 \u00b1 0.3 kg\/m2) underwent an oral glucose tolerance test (OGTT). Newly identified diabetes was found in 19% (n = 100), and impaired fasting glucose (IFG) and\/or impaired glucose tolerance (IGT) was found in 36% (n = 191). Thus, only 45% (n = 240) had normal glucose tolerance (NGT). The homeostasis model assessment of insulin resistance (HOMA-IR) was used to estimate insulin sensitivity; \u03b2-cell function was quantified as the ratio of the incremental insulin to glucose responses over the first 30 min during the OGTT (\u0394I30\/\u0394G30). This latter measure was also adjusted for insulin sensitivity as it modulates \u03b2-cell function ([\u0394I30\/\u0394G30]\/HOMA-IR). Decreasing glucose tolerance was associated with increasing insulin resistance (HOMA: NGT 12.01 \u00b1 0.54 pmol\/mmol; IFG\/IGT 16.14 \u00b1 0.84; diabetes 26.99 \u00b1 2.62; P &amp;lt; 0.001) and decreasing \u03b2-cell function (\u0394I30\/\u0394G30: NGT 157.7 \u00b1 9.7 pmol\/mmol; IFG\/IGT 100.4 \u00b1 5.4; diabetes 57.5 \u00b1 7.3; P &amp;lt; 0.001). Decreasing \u03b2-cell function was also identified when adjusting this measure for insulin sensitivity ([\u0394I30\/\u0394G30]\/HOMA-IR). In all four ethnic groups (African-American, n = 55; Asian-American, n = 66; Caucasian, n = 217; Hispanic-American, n = 193), IFG\/IGT and diabetic subjects exhibited progressively increasing insulin resistance and decreasing \u03b2-cell function. The relationships of insulin sensitivity and \u03b2-cell function to glucose disposal, as measured by the incremental glucose area under the curve (AUCg), were examined in the whole cohort. Insulin sensitivity and AUCg were linearly related so that insulin resistance was associated with poorer glucose disposal (r2 = 0.084, P &amp;lt; 0.001). In contrast, there was a strong inverse curvilinear relationship between \u03b2-cell function and AUCg such that poorer insulin release was associated with poorer glucose disposal (log[\u0394I30\/\u0394G30]: r2 = 0.29, P &amp;lt; 0.001; log[(\u0394I30\/\u0394G30)\/HOMA-IR]: r2 = 0.45, P &amp;lt; 0.001). Thus, abnormal glucose metabolism is common in first-degree relatives of subjects with type 2 diabetes. Both insulin resistance and impaired \u03b2-cell function are associated with impaired glucose metabolism in all ethnic groups, with \u03b2-cell function seeming to be more important in determining glucose disposal.<\/jats:p>","DOI":"10.2337\/diabetes.51.7.2170","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"2170-2178","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":258,"title":["\u03b2-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S."],"prefix":"10.2337","volume":"51","author":[{"given":"Christine C.","family":"Jensen","sequence":"first","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cnop","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Hull","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred Y.","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Kahn","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the American Diabetes Association GENNID Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031222582029400_R1","doi-asserted-by":"crossref","unstructured":"DeFronzo RA: The triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes\u200837:667\u2013687, 1988","DOI":"10.2337\/diab.37.6.667"},{"key":"2022031222582029400_R2","doi-asserted-by":"crossref","unstructured":"Porte D Jr: \u03b2-cells in type II diabetes mellitus. Diabetes\u200840:166\u2013180, 1991","DOI":"10.2337\/diab.40.2.166"},{"key":"2022031222582029400_R3","doi-asserted-by":"crossref","unstructured":"Kahn SE: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab\u200886:4047\u20134058, 2001","DOI":"10.1210\/jcem.86.9.7713"},{"key":"2022031222582029400_R4","doi-asserted-by":"crossref","unstructured":"Polonsky KS, Sturis J, Bell GI: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med\u2008334:777\u2013783, 1996","DOI":"10.1056\/NEJM199603213341207"},{"key":"2022031222582029400_R5","doi-asserted-by":"crossref","unstructured":"Pratley RE, Weyer C: The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia\u200844:929\u2013945, 2001","DOI":"10.1007\/s001250100580"},{"key":"2022031222582029400_R6","doi-asserted-by":"crossref","unstructured":"Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med\u2008113:909\u2013915, 1990","DOI":"10.7326\/0003-4819-113-12-909"},{"key":"2022031222582029400_R7","doi-asserted-by":"crossref","unstructured":"Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA\u2008273:1855\u20131861, 1995","DOI":"10.1001\/jama.273.23.1855"},{"key":"2022031222582029400_R8","doi-asserted-by":"crossref","unstructured":"Fernandez-Castaner M, Biarnes J, Camps I, Ripolles J, Gomez N, Soler J: Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet Med\u200813:953\u2013959, 1996","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<953::AID-DIA257>3.0.CO;2-V"},{"key":"2022031222582029400_R9","doi-asserted-by":"crossref","unstructured":"Eriksson J, Franssila Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med\u2008321:337\u2013343, 1989","DOI":"10.1056\/NEJM198908103210601"},{"key":"2022031222582029400_R10","doi-asserted-by":"crossref","unstructured":"Chen K-W, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY: Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men. Diabetes Care\u200818:747\u2013753, 1995","DOI":"10.2337\/diacare.18.6.747"},{"key":"2022031222582029400_R11","doi-asserted-by":"crossref","unstructured":"Haffner SM, Miettinen H, Stern MP: Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia\u200840:62\u201366, 1997","DOI":"10.1007\/s001250050643"},{"key":"2022031222582029400_R12","doi-asserted-by":"crossref","unstructured":"Bergstrom RW, Newell Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes\u200839:104\u2013111, 1990","DOI":"10.2337\/diacare.39.1.104"},{"key":"2022031222582029400_R13","doi-asserted-by":"crossref","unstructured":"Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes\u200844:1386\u20131391, 1995","DOI":"10.2337\/diabetes.44.12.1386"},{"key":"2022031222582029400_R14","doi-asserted-by":"crossref","unstructured":"Pontiroli AE, Monti LD, Costa S, Sandoli PE, Pizzini A, Solerte SB, Mantovani E, Piatti PM: In middle-aged siblings of patients with type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion: the SPIDER study. Eur J Endocrinol\u2008143:681\u2013686, 2000","DOI":"10.1530\/eje.0.1430681"},{"key":"2022031222582029400_R15","doi-asserted-by":"crossref","unstructured":"Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF: Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol\u2008137:719\u2013732, 1993","DOI":"10.1093\/oxfordjournals.aje.a116732"},{"key":"2022031222582029400_R16","doi-asserted-by":"crossref","unstructured":"Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care\u200823:465\u2013471, 2000","DOI":"10.2337\/diacare.23.4.465"},{"key":"2022031222582029400_R17","doi-asserted-by":"crossref","unstructured":"Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care\u200814:890\u2013896, 1991","DOI":"10.2337\/diacare.14.10.890"},{"key":"2022031222582029400_R18","doi-asserted-by":"crossref","unstructured":"Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M: Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care\u200818:1020\u20131022, 1995","DOI":"10.2337\/diacare.18.7.1020"},{"key":"2022031222582029400_R19","doi-asserted-by":"crossref","unstructured":"Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA, Brown MD, Miller M, Avery PJ, Alberti KG, Walker M: Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia\u200840:1185\u20131190, 1997","DOI":"10.1007\/s001250050805"},{"key":"2022031222582029400_R20","doi-asserted-by":"crossref","unstructured":"Ishikawa M, Pruneda ML, Adams-Huet B, Raskin P: Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes\u200847:788\u2013792, 1998","DOI":"10.2337\/diabetes.47.5.788"},{"key":"2022031222582029400_R21","doi-asserted-by":"crossref","unstructured":"Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey 1988\u20131994. Diabetes Care\u200821:518\u2013524, 1998","DOI":"10.2337\/diacare.21.4.518"},{"key":"2022031222582029400_R22","doi-asserted-by":"crossref","unstructured":"Fujimoto WY, Leonetti DL, Kinyoun JL, Newell Morris L, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes\u200836:721\u2013729, 1987","DOI":"10.2337\/diabetes.36.6.721"},{"key":"2022031222582029400_R23","doi-asserted-by":"crossref","unstructured":"Fujimoto WY, Leonetti DL, Bergstrom RW, Kinyoun JL, Stolov WC, Wahl PW: Glucose intolerance and diabetic complications among Japanese-American women. Diabetes Res Clin Pract\u200813:119\u2013129, 1991","DOI":"10.1016\/0168-8227(91)90042-C"},{"key":"2022031222582029400_R24","doi-asserted-by":"crossref","unstructured":"Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol\u2008129:295\u2013311, 1989","DOI":"10.1093\/oxfordjournals.aje.a115134"},{"key":"2022031222582029400_R25","doi-asserted-by":"crossref","unstructured":"Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med\u2008319:1500\u20131506, 1988","DOI":"10.1056\/NEJM198812083192302"},{"key":"2022031222582029400_R26","doi-asserted-by":"crossref","unstructured":"Muneta B, Newman J, Wetterall S, Stevenson J: Diabetes and associated risk factors among Native Americans. Diabetes Care\u200816:1619\u20131620, 1993","DOI":"10.2337\/diacare.16.12.1619"},{"key":"2022031222582029400_R27","doi-asserted-by":"crossref","unstructured":"Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care\u200820:185\u2013187, 1997","DOI":"10.2337\/diacare.20.2.185"},{"key":"2022031222582029400_R28","doi-asserted-by":"crossref","unstructured":"Boyko EJ, Keane EM, Marshall JA, Hamman RF: Higher insulin and C-peptide concentrations in Hispanic population at high risk for non-insulin-dependent diabetes mellitus. San Luis Valley Diabetes Study. Diabetes\u200840:509\u2013515, 1991","DOI":"10.2337\/diabetes.40.4.509"},{"key":"2022031222582029400_R29","doi-asserted-by":"crossref","unstructured":"Chiu KC, Cohan P, Lee NP, Chuang LM: Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care\u200823:1353\u20131358, 2000","DOI":"10.2337\/diacare.23.9.1353"},{"key":"2022031222582029400_R30","doi-asserted-by":"crossref","unstructured":"Haffner SM, D\u2019Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, et al: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes\u200845:742\u2013748, 1996","DOI":"10.2337\/diabetes.45.6.742"},{"key":"2022031222582029400_R31","doi-asserted-by":"crossref","unstructured":"Osei K, Schuster DP: Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring. Am J Hypertens\u20089:1157\u20131164, 1996","DOI":"10.1016\/S0895-7061(96)00248-8"},{"key":"2022031222582029400_R32","doi-asserted-by":"crossref","unstructured":"Osei K, Schuster DP: Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med\u200811:755\u2013762, 1994","DOI":"10.1111\/j.1464-5491.1994.tb00349.x"},{"key":"2022031222582029400_R33","doi-asserted-by":"crossref","unstructured":"Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkanen L, Karter AJ, Hamman R, Saad MF: Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes\u200846:63\u201369, 1997","DOI":"10.2337\/diabetes.46.1.63"},{"key":"2022031222582029400_R34","doi-asserted-by":"crossref","unstructured":"Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Permutt MA, Chiu KC, Cruz J, Ehrmann DA, Robertson RP, Rotter JI, Buse J: The GENNID Study. A resource for mapping the genes that cause NIDDM. Diabetes Care\u200819:864\u2013872, 1996","DOI":"10.2337\/diacare.19.8.864"},{"key":"2022031222582029400_R35","doi-asserted-by":"crossref","unstructured":"American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care\u200820:1183\u20131197, 1997","DOI":"10.2337\/diacare.20.7.1183"},{"key":"2022031222582029400_R36","doi-asserted-by":"crossref","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia\u200828:412\u2013419, 1985","DOI":"10.1007\/BF00280883"},{"key":"2022031222582029400_R37","doi-asserted-by":"crossref","unstructured":"Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: evidence for a hyperbolic function. Diabetes\u200842:1663\u20131672, 1993","DOI":"10.2337\/diabetes.42.11.1663"},{"key":"2022031222582029400_R38","doi-asserted-by":"crossref","unstructured":"Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes\u200846:701\u2013710, 1997","DOI":"10.2337\/diabetes.46.4.701"},{"key":"2022031222582029400_R39","doi-asserted-by":"crossref","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med\u2008344:1343\u20131350, 2001","DOI":"10.1056\/NEJM200105033441801"},{"key":"2022031222582029400_R40","doi-asserted-by":"crossref","unstructured":"Howard G, Bergman R, Wagenknecht LE, Haffner SM, Savage PJ, Saad MF, Laws A, D\u2019Agostino RB Jr: Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the \u201cminimal model\u201d: Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol\u20088:358\u2013369, 1998","DOI":"10.1016\/S1047-2797(98)00002-7"},{"key":"2022031222582029400_R41","doi-asserted-by":"crossref","unstructured":"Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care\u200822:818\u2013822, 1999","DOI":"10.2337\/diacare.22.5.818"},{"key":"2022031222582029400_R42","doi-asserted-by":"crossref","unstructured":"Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care\u200823:57\u201363, 2000","DOI":"10.2337\/diacare.23.1.57"},{"key":"2022031222582029400_R43","doi-asserted-by":"crossref","unstructured":"Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and \u03b2-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest\u200868:1456\u20131467, 1981","DOI":"10.1172\/JCI110398"},{"key":"2022031222582029400_R44","doi-asserted-by":"crossref","unstructured":"Bergman RN: Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes\u200838:1512\u20131527, 1989","DOI":"10.2337\/diab.38.12.1512"},{"key":"2022031222582029400_R45","doi-asserted-by":"crossref","unstructured":"Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest\u2008104:787\u2013794, 1999","DOI":"10.1172\/JCI7231"},{"key":"2022031222582029400_R46","doi-asserted-by":"crossref","unstructured":"Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med\u2008326:22\u201329, 1992","DOI":"10.1056\/NEJM199201023260104"},{"key":"2022031222582029400_R47","doi-asserted-by":"crossref","unstructured":"Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism\u200843:1549\u20131557, 1994","DOI":"10.1016\/0026-0495(94)90015-9"},{"key":"2022031222582029400_R48","doi-asserted-by":"crossref","unstructured":"Bruce DG, Chisholm DJ, Storlein LH, Kraegen EW: Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes\u200837:736\u2013744, 1988","DOI":"10.2337\/diabetes.37.6.736"},{"key":"2022031222582029400_R49","doi-asserted-by":"crossref","unstructured":"Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S: Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes\u200848:99\u2013105, 1999","DOI":"10.2337\/diabetes.48.1.99"},{"key":"2022031222582029400_R50","doi-asserted-by":"crossref","unstructured":"Luzi L, DeFronzo RA: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol\u2008257:E241\u2013E246, 1989","DOI":"10.1152\/ajpendo.1989.257.2.E241"},{"key":"2022031222582029400_R51","doi-asserted-by":"crossref","unstructured":"Olefsky JM, Reaven GM: Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes\u200823:449\u2013453, 1974","DOI":"10.2337\/diab.23.5.449"},{"key":"2022031222582029400_R52","doi-asserted-by":"crossref","unstructured":"Larsson H, Lindgarde F, Berglund G, Ahren B: Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study. Diabetologia\u200843:1224\u20131228, 2000","DOI":"10.1007\/s001250051516"},{"key":"2022031222582029400_R53","doi-asserted-by":"crossref","unstructured":"DECODE Study Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia\u200842:647\u2013654, 1999","DOI":"10.1007\/s001250051211"},{"key":"2022031222582029400_R54","doi-asserted-by":"crossref","unstructured":"Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980\u20131985 World Health Organization diagnostic criteria. Diabetes Care\u200820:1859\u20131862, 1997","DOI":"10.2337\/diacare.20.12.1859"},{"key":"2022031222582029400_R55","doi-asserted-by":"crossref","unstructured":"Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY: Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. Diabetes Care\u200824:39\u201344, 2001","DOI":"10.2337\/diacare.24.1.39"},{"key":"2022031222582029400_R56","doi-asserted-by":"crossref","unstructured":"Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D Jr: Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab\u200870:1247\u20131253, 1990","DOI":"10.1210\/jcem-70-5-1247"},{"key":"2022031222582029400_R57","doi-asserted-by":"crossref","unstructured":"Kahn SE, Halban PA: Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes\u200846:1725\u20131732, 1997","DOI":"10.2337\/diabetes.46.11.1725"},{"key":"2022031222582029400_R58","doi-asserted-by":"crossref","unstructured":"Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia\u200831:355\u2013360, 1988","DOI":"10.1007\/BF02341503"},{"key":"2022031222582029400_R59","doi-asserted-by":"crossref","unstructured":"Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M: Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia\u200838:1176\u20131182, 1995","DOI":"10.1007\/BF00422366"},{"key":"2022031222582029400_R60","doi-asserted-by":"crossref","unstructured":"Kahn SE, Leonetti DL, Prigeon RL, Bergstrom RW, Fujimoto WY: Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese American men: impact of obesity. J Clin Endocrinol Metab\u200880:1399\u20131406, 1995","DOI":"10.1210\/jcem.80.4.7714116"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/51\/7\/2170\/341233\/db0702002170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/51\/7\/2170\/341233\/db0702002170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:14:58Z","timestamp":1667405698000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/51\/7\/2170\/34574\/Cell-Function-Is-a-Major-Contributor-to-Oral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.51.7.2170","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}